Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMEPRAZOLE 1 – Dose-finding and population pharmacokinetics of omeprazole in neonates with gastro‑esophageal reflux
2006-005335-16Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Binary success/failure outcome and Population pharmacokinetics of omeprazole. Started Jan 2007; status: active.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-005335-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005335-16.